P
2020
The global home medical equipment market size was valued at $30,545.34 million in 2019, and is estimated to reach $56,457.87 million by 2027, registering a CAGR of 6.1% ...
Report Code : A04075 | Pages : 302 | Category : Life Sciences
P
2017
The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis ...
Report Code : A03806 | Pages : 231 | Category : Life Sciences
P
2022
The global diabetes care devices market was valued at $20.0 billion in 2020, and is projected to reach $38.3 billion by 2030, growing at a CAGR of 6.6% from 2021 to 2030.
Report Code : A02507 | Pages : 180 | Category : Life Sciences
P
2019
The safety needles market accounted for $1,609 million in 2018, and is expected to reach $3,009 million by 2026, registering a CAGR of 8.1% from 2019 to 2026.
Report Code : A03519 | Pages : 313 | Category : Life Sciences
P
2021
The global digital therapeutics market size was valued at $3,845.74 Million in 2021, and is projected to reach $22,601.97 Million by 2031, registering a CAGR of 19.4% from 2022 to 2031.
Report Code : A01787 | Pages : 300 | Category : Life Sciences
P
2022
The global diabetic retinopathy market size was valued at $3,086.00 million in 2020, and is projected to reach $10,785.50 million by 2030, registering a CAGR of 13.7% from 2021 to 2030.
Report Code : A01680 | Pages : 157 | Category : Life Sciences
P
2023
The global api intermediate market was valued at $139.4 billion in 2022, and is projected to reach $285 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032.
Report Code : A02308 | Pages : 390 | Category : Life Sciences
P
2022
The global diabetes therapeutics market was valued at $118,063.3 million in 2020, and is projected to reach $317,915 million by 2030, growing at a CAGR of 10.4% from 2021 to 2030
Report Code : A03202 | Pages : 160 | Category : Life Sciences
P
2022
The global point of care diagnostics market was valued at $29,478.63 million in 2020 and is projected to reach $55,275.73 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Report Code : A00080 | Pages : 215 | Category : Life Sciences
P
2018
Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and ...
Report Code : A00285 | Pages : 120 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.